Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 31,470 shares at $27.50 ($890K) on 2015-11-16, disclosed to the SEC on 2015-11-18.
Scheduled sale ($890k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 1,470 | $40K | 4.5% |
| 2 | $27.50 | 8,781 | $241K | 27.1% |
| 3 | $28.33 | 700 | $20K | 2.2% |
| 4 | $27.70 | 1,999 | $55K | 6.2% |
| 5 | $28.75 | 18,520 | $532K | 59.9% |
| Total | $28.27 avg | 31,470 |
| $890K |
| 100% |
| Filing → |
| ADRO | SELL | 2017-07-06 | $567K | — | Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |